News

Through the acquisition, Pfizer has gained exclusive North American commercialization rights to the FDA approved Quillivant XR. Quillivant XR (methylphenidate hydrochloride) extended-release oral suspension is indicated to treat

The sale of Bioserv will support NextPharma’s growth strategy of focusing on its core specialty and conventional product and technology operating platform in Europe. KESA Partners managing partner

Pursuant to the deal, Sanofi gains license to develop an immunotherapy to stop immune responses provoked by a food allergen. Sanofi also has a choice to develop two

The study also noted that the UK economy as a whole remains dependent on mature market export partners. UPS UK, Ireland and Nordics managing director Cindy Miller said

The study, which is the first of three phase 3 studies, had found that 78% of patients remained HCV RNA undetectable after completing the course and the safety

The particles were observed at the end of standard stability studies on retained samples. BDI has not received any customer complaints or adverse events associated with these lots.

Zytaze that contains a patent-pending mixture of organic zinc and phytase offers nutritional support to prolong the effectiveness of botulinum toxin injections. Phytase enzyme improves zinc absorption thereby

The controlled study will enroll around 45 suitable adult patients and randomize them into 2:1 ratio with either ProHema together with an unmanipulated cord blood unit or two

Based on the Hydros-TA technology, Jingfeng plans to commercialize an intra-articular therapy, designed for treating the pain associated with osteoarthritis of the knee, in China. In exchange for